About Swift Biosciences
Swift Biosciences opened its doors in February 2010 with a fully equipped laboratory facility in Ann Arbor, MI. Our company is backed by experienced private investors. Our multiple innovation platforms have been developed “in house” by our growing team of scientists and are covered by multiple patent applications.
We made our first public technical presentation the next year in February 2011. Since then we have attracted significant interest from researchers and companies looking for better solutions to challenging genetic analysis problems.
Swift will launch the first retail product in our myT™ Primers platform - myT™ BRAF - for detection of BRAF mutations in February of 2012. We are also working on additional products for mutation detection and gene sequencing, both internally and with partners.
Our company was created with the support of experienced life science investors, and Swift’s executive team has a track record of creating, marketing and selling products that are well regarded by the industry and customers alike.
